Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIF | 37.0 | 62 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIF | 24.5 | 56 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIF | 22.0 | 66 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIF | 75.5 | 52 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIF | 47.5 | 58 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIF | 20.0 | 43 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | MIF | 21.0 | 57 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIF | 23.0 | 46 | |
N2645 | TNF-a | 100 | ng/mL | 2 | MIF | 19.0 | 46 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIF | 23.0 | 49 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | MIF | 23.0 | 34 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIF | 32.0 | 49 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIF | 37.0 | 52 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIF | 36.0 | 70 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIF | 35.0 | 56 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIF | 27.0 | 42 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIF | 28.0 | 40 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIF | 32.0 | 53 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | MIF | 28.0 | 49 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIF | 33.0 | 54 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | MIF | 32.0 | 42 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIF | 31.0 | 49 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | MIF | 218.5 | 42 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIF | 25.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIF | 24.5 | 52 |